A smart drug delivery system (or targeted drug delivery system) is a method in which medication administered to a patient is concentrated more on some parts of the body than others. In conventional drug delivery systems, the drug is distributed throughout the human body via the blood stream. The disadvantage of this system is that only a small portion of the drug reaches the unhealthy organ or tissues. It can also cause side effects by affecting other healthy tissues.
Smart drug delivery seeks to prevent all such issues by increasing the drug concentration on diseased tissues while reducing side effects. Their advantages include increased treatment efficacy, increased specific localization, decreased toxic side effects, reduced dosage, improved patient compliance, and controlled bio distribution.
The advanced and targeted drug delivery market is expected to grow from its 2016 figure of US $168 billion to US $319 billion, clocking a CAGR of 10.4%. In comparison, the global drug delivery system market was US $510 billion in 2016 and is expected to surpass US $900 billion by 2025 – with a CAGR of 6.9%. This IP landscape report provides insights into the patents addressing the technologies and applications related to smart drug delivery systems.
Relecura’s forte is its flexibility and adaptability to address specific problems and close-fitting solutions. The basic problem is that innovators are often not able to identify the industrial and commercial significance of their innovation as due diligence takes long days of analyses, necessitating a deviation from their regular and familiar activities. And it is a tedious iteration process. The latest custom AI capabilities help you assess the commercial value of innovation and technical due diligence can be automated to yield meaningful and immediate results. The repetitive tasks could be automated, and your time and energy could be devoted to strategic missions.
Management of large Innovation data is costly and labor intensive. Relecura offers AI-powered classification tools for categorizing and organizing data automatically and instantly. Automated Categorization against suitably chosen training documents keeps your innovation portfolio updated and lucidly classified, amenable to instant analyses.
Relecura offers fully automated custom AI solutions to track and explore developments in different technology areas. You can stay updated on the latest developments in different companies and technologies of your interest, which facilitates intelligent decision-making.
Competitive intelligence is a prerequisite for strategic decision making. Relecura provides tools to track the innovation and publication dynamics of your competitors, based on which you can prioritize your innovation initiatives and thus hone up your competitive edge.
Relecura uses white space analysis within its product platform known as the TechTracker, an AI-powered tool that provides insights on various technological trends and offers a peep into your competitor’s patent arsenal. Additionally, it helps you keep track of emerging organizations and technologies to help you manage your budgets and investments, optimally.
Make faster, better technology decisions with Relecura
Our professional services offer training and support to minimise time-to-value on the Relecura platform and make more timely, confident IP decisions